Overview and Usage

Brand name – Gefticip

Generic name – Gefitinib

Manufacturer – CIPLA

Strength – 250mg

Dosage Form – Tablet

Composition – Gefitinib

Indication – Lung Cancer

Storage – at 20° – 25° C

Overview of Gefticip 250mg tablet

Gefticip 250mg tablet is a chemotherapy medication that is used in the treatment of non-small cell lung cancer (NSCLC). The generic name of this medication is Gefitinib. It is a tyrosine kinase inhibitor that shows antineoplastic activity. Gefticip is used in the first-line treatment of lung cancer that has genetic mutations.


Gefticip functions by blocking the action of EGFR tyrosine kinase which binds to the ATP binding site of the enzyme. EGFR refers to epidermal growth factor receptor and it is often overexpressed in cancerous cells, which furthermore leads to stimulation of anti-apoptotic signals. In addition, it causes cell proliferation as well. Gefticip has antineoplastic activity hence it stops the growth and spreading of cancer cells.

Side Effects

  • Mouth sores
  • Dry skin
  • Loss of appetite
  • Blisters of skin
  • Vomiting
  • Hives on the skin
  • Shortness of breath
  • Dark coloration of urine
  • Yellowing of skin and eyes
  • Nausea
  • Sensitivity to light
  • Vision complications
  • Acne
  • Extreme weakness
  • Diarrhea


Gefticip 250mg tablet is prescribed by the doctor hence, it is advisable to follow the prescription given as it is taken orally once every day and it can be taken with or without food.

Missed dose

It is advisable to avoid missing any doses of Gefticip and in case you miss a dose of Gefticip consult your doctor immediately.


In case of an overdose of Gefticip, contact your doctor or any healthcare provider and seek medical attention immediately.


  • Gefticip can cause allergies in some patients hence, it is necessary to read the complete composition list and consult the doctor in case of any ingredient that induces allergies.
  • Inform the doctor about all the vitamin supplements, herbal medications, and prescription and non-prescription drugs since Gefticip can interact with them.
  • It is advisable to avoid pregnancy and breastfeeding during and till two weeks after the last dose of Gefticip tablets.
  • Also, take the Gefticip tablets six hours before or after taking antacids or H2 blocker medicines like cimetidine or ranitidine.
  • Avoid alcohol consumption and also avoid operating heavy machinery during the treatment with Gefticip.
  • Inform the doctor about past medical conditions like pulmonary fibrosis, lung complications, and liver disorders.